Literature DB >> 12408981

Electroporation in combination with a plasmid vector containing SV40 enhancer elements results in increased and persistent gene expression in mouse muscle.

Pontus Blomberg1, Malihe Eskandarpour, Song Xia, Christer Sylvén, Khalid B Islam.   

Abstract

Gene transfer into muscle upon injection of plasmid DNA is feasible but occurs with low frequency. However, by using electroporation after injection of plasmid DNA into mouse muscle it has been demonstrated that gene expression can be increased more than 150-fold. In this communication, we have used this technique in combination with plasmids containing a tandem repeat of three 72-bp DNA elements from the SV40 enhancer to study gene expression. Our results show that the combination of electroporation and a plasmid vector carrying these DNA elements results in increased and more persistent gene expression of the luciferase reporter gene in BALB/c mouse muscle. At 14 days after gene delivery, the gene expression was 16-fold higher in muscles injected and electroporated with the plasmid carrying the SV40 enhancers than with control plasmid. We have also studied the effects of the vehicle in which the plasmid was delivered, and the DNase inhibitor aurintricarboxylic acid (ATA), on gene expression. By combining ATA with 150 mM sodium phosphate buffer we were able to obtain a 2-fold increase in gene expression compared to delivery of the plasmid in physiological saline. These results are of importance for the development of efficient delivery techniques for naked DNA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408981     DOI: 10.1016/s0006-291x(02)02486-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Lung NF-kappaB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia.

Authors:  Matthew R Jones; Benjamin T Simms; Michal M Lupa; Mariya S Kogan; Joseph P Mizgerd
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

Review 2.  Intracellular trafficking of nucleic acids.

Authors:  Rui Zhou; R Christopher Geiger; David A Dean
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

Review 3.  Nuclear entry of nonviral vectors.

Authors:  D A Dean; D D Strong; W E Zimmer
Journal:  Gene Ther       Date:  2005-06       Impact factor: 5.250

Review 4.  Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals.

Authors:  David A Dean
Journal:  Am J Physiol Cell Physiol       Date:  2005-08       Impact factor: 4.249

Review 5.  Intracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear import.

Authors:  Erin E Vaughan; James V DeGiulio; David A Dean
Journal:  Curr Gene Ther       Date:  2006-12       Impact factor: 4.391

6.  Optimization of an electroporation protocol using the K562 cell line as a model: role of cell cycle phase and cytoplasmic DNAses.

Authors:  Andrés Delgado-Cañedo; Daniel Garcia Dos Santos; José Artur Bogo Chies; Kátia Kvitko; Nance Beyer Nardi
Journal:  Cytotechnology       Date:  2006-11-14       Impact factor: 2.058

7.  Cyclic stretch-induced nuclear localization of transcription factors results in increased nuclear targeting of plasmids in alveolar epithelial cells.

Authors:  Anna P Lam; David A Dean
Journal:  J Gene Med       Date:  2008-06       Impact factor: 4.565

8.  Gene transfer of interleukin 10 to the murine cornea using electroporation.

Authors:  Rui Zhou; David A Dean
Journal:  Exp Biol Med (Maywood)       Date:  2007-03

Review 9.  Cell-specific targeting strategies for electroporation-mediated gene delivery in cells and animals.

Authors:  David A Dean
Journal:  J Membr Biol       Date:  2013-03-24       Impact factor: 1.843

10.  Enhanced Immune Response to DNA Vaccine Encoding Bacillus anthracis PA-D4 Protects Mice against Anthrax Spore Challenge.

Authors:  Na Young Kim; Dong Suk Chang; Yeonsu Kim; Chang Hwan Kim; Gyeung Haeng Hur; Jai Myung Yang; Sungho Shin
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.